Stocks of Pfizer Inc (NYSE:PFE) traded higher last session on Wall Street, down -1.82% to $23.18.
PFE stock price is now -1.45% away from the 50-day moving average and -12.02% away from the 200-day moving average. The market capitalization of the company currently stands at $131.79B.
With the price target of $24, Cantor Fitzgerald recently initiated with Neutral rating for Pfizer Inc (NYSE: PFE)., while ‘Wolfe Research’ rates the stock as ‘Underperform’
In other news, Dolsten Mikael, Former Officer bought 59,781 shares of the company’s stock on May 23 ’25. The stock was bought for $1,380,632 at an average price of $23.09. An SEC document containing details of the transaction can be found on the SEC’s website. On May 05 ’25, Former Officer Dolsten Mikael bought 55,000 shares of the business’s stock. A total of $1,312,736 was incurred on buying the stock at an average price of $23.87. A total of 0.18% of the company’s stock is owned by insiders.
During the past 12 months, Pfizer Inc has had a low of $20.92 and a high of $31.54. As of last week, the company has a debt-to-equity ratio of 0.69, a current ratio of 1.26, and a quick ratio of 0.96.
The net profit margin was 12.59% and return on equity was 8.62% for PFE. The company reported revenue of $13.71 billion for the quarter, compared to $14.88 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -7.82 percent. For the current quarter, analysts expect PFE to generate $13.43B in revenue.
